Skip to main content
Evaxion biotech Logo
  • About us
    • Overview
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • AI platform technologies
  • Pipeline
    • Overview
    • EVX-01 clinical trial
  • Investors
    • Overview
  • News & Events
    • Press Releases
    • Stay in Touch
  • Careers
  • Contact
    • Information Request Form
    • Contact us

Site Search

Press Releases

  • About us
    • Overview
    • Who We Are
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • AI platform technologies
  • Pipeline
    • Overview
    • EVX-01 clinical trial
  • Investors
    • Overview
  • News & Events
    • Press Releases
    • Stay in Touch
  • Careers
  • Contact
    • Information Request Form
    • Contact us
Normal
Press release year list 2021 2020 2019 2018 2017 2016
12/23/2020
Evaxion Biotech doses first patient in Phase I/IIa melanoma trial of cancer vaccine EVX-02 in combination with checkpoint inhibitors
DownloadPDF format download (opens in new window)
12/17/2020
Evaxion Biotech appoints Marianne Søgaard as Chairwoman
DownloadPDF format download (opens in new window)
12/09/2020
EU Boosts Evaxion’s Artificial Intelligence Vaccine Research
12/09/2020
Evaxion Biotech announces publication in Nature Communications describing improved selection of immunotherapy targets
10/22/2020
SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology
10/02/2020
Evaxion Biotech Launches New AI Powered Platform, RAVEN, to Enable Faster Response to Emerging Viral Pandemics
07/22/2020
Evaxion Biotech among the top 16 global companies using artificial intelligence to revolutionize drug discovery, according to experts from Frost & Sullivan
© Copyright EVAXION BIOTECH A/S - All rights reserved
Powered By Q4 Inc. 5.50.0.4 (opens in new window)